Currently, there are 98.88M common shares owned by the public and among those 98.54M shares have been available to trade.
The company’s stock has a 5-day price change of -3.97% and -5.93% over the past three months. STE shares are trading -1.52% year to date (YTD), with the 12-month market performance up to 1.35% higher. It has a 12-month low price of $195.47 and touched a high of $254.00 over the same period. STE has an average intraday trading volume of 554.96K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -4.17%, -0.39%, and -1.06% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Steris Plc (NYSE: STE) shares accounts for 97.89% of the company’s 98.88M shares outstanding.
It has a market capitalization of $21.40B and a beta (3y monthly) value of 0.82. The stock’s trailing 12-month PE ratio is 56.86, while the earnings-per-share (ttm) stands at $3.81. The company has a PEG of 5.69 and a Quick Ratio of 2.36 with the debt-to-equity ratio at 0.54. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.77% over the week and 1.69% over the month.
Earnings per share for the fiscal year are expected to increase by 11.50%, and 10.06% over the next financial year. EPS should grow at an annualized rate of 10.00% over the next five years, compared to 1.36% over the past 5-year period.
Looking at the support for the STE, a number of firms have released research notes about the stock. KeyBanc Capital Markets stated their Overweight rating for the stock in a research note on February 06, 2024, with the firm’s price target at $253. Morgan Stanley coverage for the Steris Plc (STE) stock in a research note released on May 30, 2023 offered a Equal-Weight rating with a price target of $206. Piper Sandler on their part issued Overweight rating on July 14, 2022.
